NCT00183976

Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas

A Pilot Phase II Study of Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 15 (planned)
• Sponsor: University of Southern California · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study is for patients who have been treated before and either the treatment did not work or the lymphoma has come back.

Conditions

• Non-Hodgkin's Lymphoma
• Burkitt Lymphoma
• Primary Effusion Lymphomas

Interventions

Type	Name	Description
DRUG	Pegylated Liposomal Doxorubicin (Doxil) and Rituximab

Timeline

• Start date: 2005-04-01
• Primary completion: 2005-09-01
• Completion: 2006-01-01
• First posted: 2005-09-16
• Last updated: 2014-05-22

Locations

1 site across 1 country: United States